| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.29 | 0.03 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.32 | 0.03 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.28 | 0.03 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |